In summary, this study found that miR-122 could repress the LKB1/AMPK signalling pathway via directly downregulating Sirt1, which then induced steatosis and lipogenesis in NAFLD. The gene discussed is STK11; the disease is metabolic dysfunction-associated steatotic liver disease.